葉俊男

葉俊男看診時間

星期一	24 小時營業
星期二	24 小時營業
星期三	24 小時營業
星期四	24 小時營業
星期五	24 小時營業
星期六	24 小時營業
星期日	24 小時營業

葉俊男醫師簡介

現職

台灣分子醫學會理事長
台灣消化系外科醫學會理事

學歷

美國約翰霍普金斯大學
台北醫學院醫學系

經歷

林口長庚紀念醫院一般外科系系主任
林口長庚紀念醫院一般外科系一般外科科主任
桃園長庚紀念醫院一般外科科主任
台灣胰臟醫學會秘書長

學會與認證

中華民國癌症醫學會
台灣消化外科醫學會
台灣內視鏡外科醫學會
台灣內分泌外科醫學會
台灣胰臟醫學會
世界肝膽胰外科醫學會
世界消化道外科醫學

論文及期刊發表

Genomic landscape and comparative analysis of tissue and liquid-based NGS in Taiwanese anaplastic thyroid carcinoma.
NPJ Precis Oncol. 2025 Jan 14;9(1):16.
Yeh CN, Lin SF, Wu CL, Liou MJ, Chen IW, Chen CP, Chang CF, Wang QA, Wu CE.
Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study.
BMC Cancer. 2024 Jul 11;24(1):828.
Tsai HJ, Shan YS, Yang CY, Hsiao CF, Tsai CH, Wang CC, Lin MT, Ting CF, Chan DC, Chen TH, Yen CC, Chen YY, Lin HY, Yeh TS, Ho CL, Shieh TY, Bai LY, Hsu JT, Chen IS, Chen LT*, Yeh CN* Taiwan Cooperative Oncology Group (TCOG) GIST Study Group.
Efficacy of first-line combination therapies versus gemcitabine monotherapy for advanced pancreatic cancer: a systematic review and network meta-analysis.
Am J Cancer Res. 2024 Jul 15;14(7):3523-3532.
Huang WK, Hung YL, Tsai CY, Wu CE, Chou WC, Hsu JT, Yeh TS, Chen JS, Wang SY*, Yeh CN*(共同指導).
The Clinical Impact of Different Types of Preoperative Biliary Intervention on Postoperative Biliary Tract Infection of Patients Undergoing Pancreaticoduodenectomy.
J Clin Med. 2024 Jul 16;13(14):4150
Wu MJ, Chan YY(共同第一), Chen MY, Hung YL, Kou HW, Tsai CY, Hsu JT, Yeh TS, Hwang TL, Jan YY, Wu CH, Liu NJ, Wang SY*, Yeh CN*.(共同指導).
Zinc supplementation decreased incidence of grade ≧2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial.
J Am Acad Dermatol. 2024 Feb;90(2):368-369.
Huang WK, Hsu HC, Yang TS, Lu CW, Pan YR, Wu CE, Chung WH, Hung SI, Yeh CN*
PLK1 and its substrate MISP facilitate intrahepatic cholangiocarcinoma progression by promoting lymphatic invasion and impairing E-cadherin adherens junctions.
Cancer Gene Ther. 2024 Feb;31(2):322-333.
Yi-Ru Pan, Joseph Chieh-Yu Lai, Wen-Kuan Huang, Pei-Hua Peng, Shih-Ming Jung, Sheng-Hsuan Lin, Chiao-Ping Chen, Chiao-En Wu, Tsai-Hsien Hung, Alice L. Yu, Kou-Juey Wu*, Chun-Nan Yeh*
A Potential Association of Zinc Deficiency and Tyrosine Kinase Inhibitor-Induced Hand-Foot Skin Reaction.
Biol Trace Elem Res. 2023 Dec;201(12):5540-5545. doi: 10.1007/s12011-023-03618-y
Yeh CN, Huang WK, Lu CW, Chen CP, Lin SH, Pan YR, Wu CE*.
Zinc supplementation decreased incidence of grade ≧ 2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial.
EJC 2023 Nov 10:113286. doi: 10.1016/j.ejca.2023.113286.
Wen-Kuan Huang, Hung-Chih Hsu, Tsai-Sheng Yang, Chun-Wei Lu, Yi-Ru Pan, Chiao-En Wu, Wen-Hung Chung, Shuen-Iu Hung, Chun-Nan Yeh*
Wee1 inhibition by MK1775 potentiates gemcitabine through accumulated replication stress leading to apoptosis in biliary tract cancer.
Biomed Pharmacother. 2023 Aug 31;166:115389. doi: 10.1016/j.biopha.2023.115389. PMID: 37659202
Chen CP, Yeh CN(共同第一), Pan YR, Huang WK, Hsiao YT, Lo CH, Wu CE
Hepatitis C accelerates extrahepatic cholangiocarcinoma risk: a joint study of hospital-based cases and nationwide population-based cohorts in a viral hepatitis-endemic area.
Am J Cancer Res 2023;13(7):3080-3090.
Shu-Wei Huang, Jur-Shan Cheng, Wei-Ting Chen, Ting-Shu Wu, Hsin-Ping Ku, Chun-Nan Yeh*,Rong-Nan Chien, Ming-Ling Chang
Mucin 4 Confers Gemcitabine Resistance and an Unfavorable Prognosis in Patients with Cholangiocarcinoma via AKT Activation.
Int. J. Biol. Sci. 2023; 19(9): 2772-2786.
Yi-Ru Pan, Chiao-En Wu(共同第一), Shih-Ming Jung, Shih-Chiang Huang, Sheng-Hsuan Lin, Wen-Chi Chou, Yu-Chan Chang, Ming-Huang Chen, Tsai-Hsien Hung, Alice L. Yu, Wen-Kuan Huang*,Chun-Nan Yeh*
Intraductal papillary neoplasm of the bile duct presenting with hepatogastric fistula: a case report and literature review.
Frontiers in Oncology. 2023 Mar 19. DOI 10.3389/fonc.2023.1193918
Wen-Hui Chan, Chien-Ming Chen, Shang-Yu Wang, Ren-Chin Wu, Tse-Ching Chen, Hao-Kang Lee, Cheng-Hui Lin, Chun-Nan Yeh*
Risk factors of recurrent secondary hyperparathyroidism after adequate primary surgical treatment.
Front Endocrinol (Lausanne) 2023 Feb 3;14:1063837. doi: 10.3389/fendo.2023.1063837.
Yu-Chi Kuo, Shang-Yu Wang(共同第一), Yu-Liang Hung, Chih-Chieh Hsu, Hao-Wei Kou, Ming-Yang Chen, Chun-Yi Tsai, Chih-Hsiang Chang, Yu-Chao Wang, Jun-Te Hsu, Ta-Sen Yeh, Wei-Chen Lee, Chun-Nan Yeh*
Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report.
JCO Precis Oncol. 2023;7:e2200528. DOI https://doi.org/10.1200/PO.22.00528
Wen-Kuan Huang, Shih-Chiang Huang, Chien-Ming Chen, Po-Hung Lin, Chiao-En Wu, Cheng-Keng Chuang, Chun-Nan Yeh*
A Potential Association of Zinc Deficiency and Tyrosine Kinase Inhibitor-Induced Hand-Foot Skin Reaction.
Biol Trace Elem Res. 2023 Mar 9. doi: 10.1007/s12011-023-03618-y.
Chun-Nan Yeh, Wen-Kuan Huang, Chun-Wei Lu, Chiao-Ping Chen, Sheng-Hsuan Lin, Yi-Ru Pan, Chiao-En Wu*.
Letter to the editors on 'Clinical efficacy of lenvatinib for the treatment of radioiodine-refractory thyroid carcinoma: A systematic review and meta-analysis of clinical trials
Clin Endocrinol (Oxf). 2023 Jan;98(1):133. doi: 10.1111/cen.14565. Epub 2021 Jul 27.
Li YR, Wang SY, Yeh CN*.